2022 Universal Registration Document

2.4.4. Summary table of the remuneration of Mr Jean-Paul Agon,Chairman of the Board of Directors

	2022		2021 (1 May to 31 December)
In €	Amounts allocated	Amounts paid	Amounts allocated	Amounts paid
Fixed remuneration⁽¹⁾	1,600,000	1,600,000	1,066,666	1,066,666
Annual variable remuneration	-	-	-	-
Exceptional remuneration	-	-	-	-
Remuneration for term of office as Director	-	-	-	-
Benefits in kind	-	-	-	-
TOTAL	1,600,000	1,600,000	1,066,666	1,066,666

(1) The fixed remuneration was paid on a pro rata basis in 2021 as the appointment of Mr Agon as Chairman of the Board took effect on 1 May 2021. The amount on an annual basis is €1,600,000.

Summary table of remuneration and performance shares awarded to M. Jean-Paul Agon, Chairman of the Board of Directors

In €	2022	2021 (1 May to 31 December)
Remuneration due in respect of the financial year⁽¹⁾	Remuneration due in respect of the financial year ⁽¹⁾2022 1 600 000	Remuneration due in respect of the financial year ⁽¹⁾2021 (1 May to 31 December) 1 066 666
Value of performance shares granted during the financial year	Value of performance shares granted during the financial year 2022 N/A	Value of performance shares granted during the financial year 2021 (1 May to 31 December) N/A
TOTAL	TOTAL 20221 600 000	TOTAL 2021 (1 May to 31 December) 1 066 666

(1) Annual fixed and variable remuneration was paid on a pro rata basis in 2021, starting from the appointment of Mr Jean-Paul Agon as Chairman of the Board from 1 May2021. The amounts indicated for 2021 cover eight months.

History of the stock options granted to Mr Jean-Paul Agon since his appointment as a corporate officer that can still be exercised at 31 December 2022

N/A.

Table of share subscription or purchase options exercised by Mr Jean-Paul during financial year2022

N/A.

History of conditional grants of shares (ACAs) to Mr Jean-Paul Agon since his appointment as a corporate officer

Grant date	Number of ACAs granted	Performance conditions	Grant value(IFRS fair value)	Date of final vesting of all or part of the ACAs	Number of finally vested shares	First possible date of sale of a portion of these ⁽⁴⁾
17 April 2012⁽¹⁾	1 7 April 2012⁽¹⁾Number of ACAs granted 50,000	1 7 April 2012⁽¹⁾Performance conditions Yes	1 7 April 2012⁽¹⁾Grant value(IFRS fair value) 3,853,500	1 7 April 2012⁽¹⁾Date of final vesting of all or part of the ACAs 18 April 2016	1 7 April 2012⁽¹⁾Number of finally vested shares 50,000	1 7 April 2012⁽¹⁾First possible date of sale of a portion of these ⁽⁴⁾18 April 2018
26 April 2013⁽¹⁾	26 April 2013⁽¹⁾Number of ACAs granted 40,000	26 April 2013⁽¹⁾Performance conditions Yes	26 April 2013⁽¹⁾Grant value(IFRS fair value) 4,494,800	26 April 2013⁽¹⁾Date of final vesting of all or part of the ACAs 27 April 2017	26 April 2013⁽¹⁾Number of finally vested shares 40,000	26 April 2013⁽¹⁾First possible date of sale of a portion of these ⁽⁴⁾ 27 April 2019
17 April 2014⁽¹⁾	17 April 2014⁽¹⁾Number of ACAs granted 40,000	17 April 2014⁽¹⁾Performance conditions Yes	17 April 2014⁽¹⁾Grant value(IFRS fair value) 4,183,200	17 April 2014⁽¹⁾Date of final vesting of all or part of the ACAs18 April 2018	17 April 2014⁽¹⁾Number of finally vested shares 40,000	17 April 2014⁽¹⁾First possible date of sale of a portion of these ⁽⁴⁾ 18 April 2020
22 April 2015⁽¹⁾	22 April 2015⁽¹⁾Number of ACAs granted 32,000	22 April 2015⁽¹⁾Performance conditions Yes	22 April 2015⁽¹⁾Grant value(IFRS fair value) 5,167,680	22 April 2015⁽¹⁾Date of final vesting of all or part of the ACAs 23 April 2019	22 April 2015⁽¹⁾Number of finally vested shares 26,432	22 April 2015⁽¹⁾First possible date of sale of a portion of these ⁽⁴⁾ 23 April 2021
20 April 2016⁽²⁾	20 April 2016⁽²⁾Number of ACAs granted 32,000	20 April 2016⁽²⁾Performance conditions Yes	20 April 2016⁽²⁾Grant value(IFRS fair value) 4,938,240	20 April 2016⁽²⁾Date of final vesting of all or part of the ACAs 21 April 2020	20 April 2016⁽²⁾Number of finally vested shares 32,000	20 April 2016⁽²⁾First possible date of sale of a portion of these ⁽⁴⁾ 21 April 2020
20 April 2017⁽²⁾	20 April 2017⁽²⁾Number of ACAs granted 32,000	20 April 2017⁽²⁾Performance conditions Yes	20 April 2017⁽²⁾Grant value(IFRS fair value) 5,340,800	20 April 2017⁽²⁾Date of final vesting of all or part of the ACAs 21 April 2021	20 April 2017⁽²⁾Number of finally vested shares 26,544	20 April 2017⁽²⁾First possible date of sale of a portion of these ⁽⁴⁾ 21 April 2021
17 April 2018⁽²⁾	17 April 2018⁽²⁾Number of ACAs granted 30,000	17 April 2018⁽²⁾Performance conditions Yes	17 April 2018⁽²⁾Grant value(IFRS fair value) 5,285,100	17 April 2018⁽²⁾Date of final vesting of all or part of the ACAs 18 April 2022	17 April 2018⁽²⁾Number of finally vested shares 30,000	17 April 2018⁽²⁾First possible date of sale of a portion of these ⁽⁴⁾ 18 April 2022
18 April 2019⁽²⁾	18 April 2019⁽²⁾Number of ACAs granted 24,000	18 April 2019⁽²⁾Performance conditions Yes	18 April 2019⁽²⁾Grant value(IFRS fair value) 5,430,000	18 April 2019⁽²⁾Date of final vesting of all or part of the ACAs 19 April 2023	18 April 2019⁽²⁾Number of finally vested shares 24,000	18 April 2019⁽²⁾First possible date of sale of a portion of these ⁽⁴⁾ 19 April 2023

(1) At the end of the vesting period, Mr Jean-Paul Agon, as a French resident on the date of granting the shares, is required to hold the fully vested shares for an additional two-year period during which the shares may not be transferred.

(2) The 20 April 2016, 20 April 2017, 17 April 2018 and 18 April 2019 Plans set a four-year vesting period, without any holding period.

(3) See the performance conditions described in chapter 7 of this document.

(4) Mr Jean-Paul Agon, as corporate officer, shall retain 50% of the fully vested shares in registered form until the end of his duties. Mr Jean-Paul Agon has undertaken not to enter into any risk hedging transactions.

Table of performance shares that became available during the 2022 financial year for Mr Jean-Paul Agon

N/A.

2022 Universal Registration Document

Chapter 2 : Corporate governance

2.4.4. Summary table of the remuneration of Mr Jean-Paul Agon,Chairman of the Board of Directors

Summary table of remuneration and performance shares awarded to M. Jean-Paul Agon, Chairman of the Board of Directors

History of the stock options granted to Mr Jean-Paul Agon since his appointment as a corporate officer that can still be exercised at 31 December 2022

Table of share subscription or purchase options exercised by Mr Jean-Paul during financial year2022

History of conditional grants of shares (ACAs) to Mr Jean-Paul Agon since his appointment as a corporate officer

Table of performance shares that became available during the 2022 financial year for Mr Jean-Paul Agon